Abstract
A simple, efficient and ecofriendly procedure for the synthesis of tetrahydrobenzo[b]pyran derivatives using triphenylphosphine as catalyst under aqueous conditions has been developed. This new method has some advantages like the easy experimental protocol, shorter reaction time, higher yields and is benign for the environment with using water as solvent.
Keywords: Aqueous medium, multicomponent reaction, one-pot synthesis, Tetrahydrobenzo[b]pyrans, triphenylphosphine
Letters in Organic Chemistry
Title:Triphenylphosphine-Catalyzed One-Pot Three Component Synthesis of Tetrahydrobenzo[b]Pyrans in Aqueous Medium
Volume: 10 Issue: 2
Author(s): Wassima Ghalem, Ramzy Hilal Sedrati, Nadjiba Benloucif, Fabienne Berree, Boudjemaa Boumoud and Abdelmadjid Debache
Affiliation:
Keywords: Aqueous medium, multicomponent reaction, one-pot synthesis, Tetrahydrobenzo[b]pyrans, triphenylphosphine
Abstract: A simple, efficient and ecofriendly procedure for the synthesis of tetrahydrobenzo[b]pyran derivatives using triphenylphosphine as catalyst under aqueous conditions has been developed. This new method has some advantages like the easy experimental protocol, shorter reaction time, higher yields and is benign for the environment with using water as solvent.
Export Options
About this article
Cite this article as:
Ghalem Wassima, Hilal Sedrati Ramzy, Benloucif Nadjiba, Berree Fabienne, Boumoud Boudjemaa and Debache Abdelmadjid, Triphenylphosphine-Catalyzed One-Pot Three Component Synthesis of Tetrahydrobenzo[b]Pyrans in Aqueous Medium, Letters in Organic Chemistry 2013; 10 (2) . https://dx.doi.org/10.2174/1570178611310020015
DOI https://dx.doi.org/10.2174/1570178611310020015 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Plasticity of the 7TMR Signaling Machinery and the Search for Pharmacological Selectivity
Current Pharmaceutical Design Physiological Insights Derived from Mathematical Models of Respiration
Current Respiratory Medicine Reviews Genetics and Vaccines in the Era of Personalized Medicine
Current Genomics Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
Current Pharmaceutical Design Targeting Wnt Signaling through Small molecules in Governing Stem Cell Fate and Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Repurposed Drugs in Metabolic Disorders
Current Topics in Medicinal Chemistry CD133+ Glioblastoma Stem-Like Cells Induce Vascular Mimicry in Vivo
Current Neurovascular Research Circadian Cycle and Chronotherapeutics: Recent Trend for the Treatment of Various Biological Disorders
Recent Patents on Drug Delivery & Formulation Subset Selection and Docking of Human P2X7 Inhibitors
Current Computer-Aided Drug Design Stress, Metaplasticity, and Antidepressants
Current Molecular Medicine Curcumin Exposure Modulates Multiple Pro-Apoptotic and Anti-Apoptotic Signaling Pathways to Antagonize Acetaminophen-Induced Toxicity
Current Neurovascular Research Opioid Alkaloids in Fire Poppies, Papaver Californicum
The Natural Products Journal Somatostatin Replacement: A New Strategy for Treating Diabetic Retinopathy
Current Medicinal Chemistry Physicochemical Characterization of Mitragyna speciosa Alkaloid Extract and Mitragynine using In Vitro High Throughput Assays
Combinatorial Chemistry & High Throughput Screening Experimental Drugs for Neuropathic Pain
Current Neuropharmacology Methylone and Monoamine Transporters: Correlation with Toxicity
Current Neuropharmacology Oligomers of β-Amyloid Peptide Inhibit BDNF-Induced Arc Expression in Cultured Cortical Neurons
Current Alzheimer Research D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Survivin Modulators: An Updated Patent Review (2011 - 2015)
Recent Patents on Anti-Cancer Drug Discovery ACE Inhibition Prevents Diastolic Ca2+ Overload and Loss of Myofilament Ca2+ Sensitivity after Myocardial Infarction
Current Molecular Medicine